L1FLCD (1173–1185) is a cytoplasmic-domain peptide derived from L1CAM, used to study intracellular adaptor-protein interactions. Its sequence contains motifs relevant to cytoskeletal linkage and phosphorylation. Researchers employ it to examine structural determinants of adhesion-mediated signaling. The peptide aids mapping of L1CAM intracellular networks.
CAT No: C15004
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.